Empowering patients to lead fully mobile lives

High risk and chronically ill patients in Europe may soon find themselves able to lead independent and fully mobile lives thanks to the work of a project that has developed a Body Area Network of wireless sensors to remotely monitor vital signs.

Aethlon Scientist to Present Strategy for Treating Drug Resistant HIV and Hepatitis-C

Aethlon Medical, Inc. (OTCBB: AEMD) announced that its Chief Scientific Officer, Dr. Richard Tullis will present today at the 25th Annual Dialysis Conference, being held at the Tampa Convention Center. The presentation is scheduled to begin at 3:00 p.m. EST. Dr. Tullis will discuss how the multi-pathogen, multi-strain clearance characteristics of the Aethlon Hemopurifier(TM) could provide new hope for individuals afflicted with drug or vaccine resistant viral infections, including HIV, the AIDS virus, and Hepatitis-C.


Diary notice - 1.5 million people in the UK have a learning disability, which affects intellectual and social development throughout their lives. Yet many of the general public are unclear about the term learning disability. Learning Disability Week aims to raise awareness of what it means to have a learning disability.

POP = Put On Protection

Over 60% of the people who will be diagnosed with skin cancer in 2005 could have avoided the disease if they had practiced a safer sun protection regimen.

Easier Access to Treatment Abroad for UK Patients

A new web site, www.treatmentabroad.net, promises to give more treatment choices to those seeking alternatives to UK based providers. Within 48 hours of completing a simple enquiry form, visitors receive quotes for treatment from three different countries or providers – available often at a much lower cost than in the UK. The site has been designed, launched and is managed by Intuition Communication.